MoneyWorks4Me

The sales for the June 2026 quarter moved up 29.73% to Rs. 6827.90 millions as compared to Rs. 5263.10 millions during the corresponding quarter last year.The Company to register a -32.06%  fall in the net profit for the quarter ended June 2026.A decline of 581.70 millions was observed in the OP in the quarter ended June 2026 from 923.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6827.90 5263.10 29.73 6827.90 5263.10 29.73 22755.80 17162.90 32.59
Other Income 92.30 112.40 -17.88 92.30 112.40 -17.88 284.90 406.30 -29.88
PBIDT 581.70 923.50 -37.01 581.70 923.50 -37.01 2905.20 2946.00 -1.38
Interest 19.50 7.20 170.83 19.50 7.20 170.83 44.90 14.60 207.53
PBDT 559.80 912.70 -38.67 559.80 912.70 -38.67 2807.80 1963.50 43.00
Depreciation 52.30 165.70 -68.44 52.30 165.70 -68.44 285.80 399.90 -28.53
PBT 507.50 747.00 -32.06 507.50 747.00 -32.06 2522.00 1563.60 61.29
TAX 128.20 188.70 -32.06 128.20 188.70 -32.06 646.80 406.20 59.23
Deferred Tax 19.50 -32.30 -160.37 19.50 -32.30 -160.37 52.60 -199.20 -126.41
PAT 379.30 558.30 -32.06 379.30 558.30 -32.06 1875.20 1157.40 62.02
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 8.52 17.55 -51.45 8.52 17.55 -51.45 12.77 17.16 -25.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..